glp-1 alcohol reduction GLP-1s tied to lower intake for adults with overweight, obesity GLP-1 receptor agonists for the
Description
doi: 10.2478/rjim-2019-0003 194 ZobelEHRipaRSvon ScholtenBJRotbain CurovicVKjaerAHansenTWet al

It was also an early observation that a higher dose of GLP-1 is needed to produce satiety and reduced food intake than to the antidiabetic effect, so a low dose GLP-1 analog could be used to study weight loss independent effects of GLP-1

A phase 2 trial has begun for ASC30 in its oral form to treat diabetes, and the drug demonstrated a 5.4%, 7%, and 7.7% decline in weight in participants who were given 20 mg, 40 mg, and 60 mg doses of the drug, respectively, in 13 weeks

Approximately 28 days when stored at 36 to 46 degrees F (2 to 8 degrees C) in a refrigerator and prepared with bacteriostatic water
However, the two classes of agents differ largely in their pharmacological modes of action on glucose-lowering and CV parameters
